HAGA.BIO

Focus where it truly matters.

Solna, Sweden · $2.3M raised

Headquarters
Solna
Employees
1–10
Business Model
B2B
Total Funding
$2.3M
Last Round
$2.3M SeedJun 2026
Rounds
1

About

HAGA.BIO develops spatial RNA assays that validate candidate biomarkers directly in real tissue at single-nucleotide and single-cell resolution, bridging discovery and translation. Its products include HAGA Pattern for in situ RNA detection, HAGA Point for in situ mutation detection, and HAGA Panorama for 10-plex RNA detection in one imaging round. Assays work with FFPE and archived tissue on existing histology infrastructure, enabling cohort-scale validation without new equipment. Research users include teams at Karolinska Institute, EPFL, and the Medical University of Graz.

Summary

HAGA.BIO is a Biotech company based in Solna, Sweden. It has raised $2.3M in total across 1 round, most recently a $2.3M Seed round in Jun 2026.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedJun 2026
$2.3M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HAGA.BIO on Indexed.vc
<a href="https://indexed.vc/companies/haga-bio"><img src="https://indexed.vc/api/badge/company/haga-bio" alt="HAGA.BIO on Indexed.vc" width="260" height="76" /></a>